Drupal.behaviors.print = function(context) {window.print();window.close();}>
Jefferies Restarts Coverage of Complete Genomics with 'Buy' Rating
June 06, 2011
Jefferies Restarts Coverage of Complete Genomics with 'Buy' Rating
Jefferies also increased the firm's stock price target to $20 from $15.50.
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
William Blair Initiates Coverage of PacBio, Complete Genomics
April 19, 2011 / GenomeWeb Daily News
Investment Firm Jefferies Resumes Coverage on Eight MDx, Genetic Testing, Tools Firms
March 11, 2011 / GenomeWeb Daily News
Investment Firms Begin Coverage of Complete Genomics
December 21, 2010 / GenomeWeb Daily News
Mizuho Initiates Coverage of Complete Genomics with Outperform Rating
September 15, 2011 / GenomeWeb Daily News
Jefferies Raises Revenue Expectations for Complete Genomics
April 18, 2011 / GenomeWeb Daily News